Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy

MLA

Juan R. Gimeno, et al. “Prevalence and Clinical Significance of Systolic Impairment in Hypertrophic Cardiomyopathy.” Heart (British Cardiac Society), vol. 91, no. 7, June 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e7e46cce256e5aedefe1f5d84aebf82c&authtype=sso&custid=ns315887.

APA

Juan R. Gimeno, Toru Kubo, J Mogensen, WJ McKenna, B Sachdev, Perry M. Elliott, Rajesh Thaman, & Ross T. Murphy. (2005). Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy. Heart (British Cardiac Society), 91(7).

Chicago

Juan R. Gimeno, Toru Kubo, J Mogensen, WJ McKenna, B Sachdev, Perry M. Elliott, Rajesh Thaman, and Ross T. Murphy. 2005. “Prevalence and Clinical Significance of Systolic Impairment in Hypertrophic Cardiomyopathy.” Heart (British Cardiac Society) 91 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e7e46cce256e5aedefe1f5d84aebf82c&authtype=sso&custid=ns315887.